Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia.

R L Nissen, A J Yonkers

    The Laryngoscope
    |October 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Malignant hyperthermia (MH) is a rare but potentially fatal anesthetic complication. Early recognition and prompt treatment are crucial for survival, as MH can be uniformly fatal without intervention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Geographic variation in allergic fungal rhinosinusitis.

    Otolaryngologic clinics of North America·2000
    Same author

    Argon laser in difficult stapedotomy cases.

    The Laryngoscope·1998
    Same author

    Outcome-oriented managed care comparing efficacies of cefaclor and amoxicillin in acute and recurrent acute otitis media.

    Ear, nose, & throat journal·1995
    Same author

    Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers.

    Chest·1995
    Same author

    Microvascular reconstruction of the head and neck cancer patient.

    The Nebraska medical journal·1993
    Same author

    Left tympanic segment facial nerve neuroma and hearing loss, but normal facial function.

    The American journal of otology·1993

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Medical Genetics

    Background:

    • Malignant hyperthermia (MH) is a severe, hypermetabolic complication of anesthesia.
    • Its exact incidence is unknown, with estimates up to 1 in 14,000 anesthetic events.
    • MH carries a high mortality rate, potentially up to 70% without timely intervention.

    Purpose of the Study:

    • To review the existing literature on malignant hyperthermia.
    • To highlight the occurrence, pathology, and clinical features of MH.
    • To emphasize the importance of early recognition and treatment strategies.

    Main Methods:

    • Comprehensive literature review of malignant hyperthermia.
    • Analysis of reported cases and epidemiological data.
    • Synthesis of information on pathophysiology and clinical presentation.

    Related Experiment Videos

    Main Results:

    • Malignant hyperthermia (MH) is a rare but life-threatening condition.
    • Mortality rates can be as high as 70% if not treated promptly.
    • Early recognition and intervention are critical for patient survival.

    Conclusions:

    • Physicians must be aware of malignant hyperthermia (MH) signs and symptoms.
    • Prompt medical intervention is essential for managing this uniformly fatal condition.
    • Understanding MH occurrence, pathology, and treatment is vital for clinical practice.